Harmony Biosciences Holdings, Inc.
S&P 600
$41.52
+1.02%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.16.
- Comfortable interest cover: operating profit covers interest about 14.2 times.
- Return on equity is healthy at 15.9%.
- Return on capital employed is healthy at 18.6%.
- Net profit margin is strong at 18.3%.
- Current assets comfortably cover current liabilities (current ratio 3.6).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
5.65
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
5 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$2.42B
Current Price$ 41.52
High / Low$ 43.49 / 25.52
Stock P/E13.436893
Book Value$ 17.01
Dividend Yield0%
ROCE18.60%
ROE15.88%
Debt to Equity0.16
Current Ratio3.60
P/B Ratio2.4149363
EPS$ 2.71
Debt$163.66M
PAT Margin18.27%
ICR14.23